- Galvez-Fernandez, Marta
- Domingo-Relloso, Arce
- Rodríguez-Hernández, Zulema
- Gonzalez-Marrachelli, Vannina
- Grau-Perez, Maria
- Morales-Tatay, José M.
- Amigo, Nuria
- Garcia-Barrera, Tamara
- Gomez-Ariza, Jose L.
- Chaves, F. Javier
- Garcia-Garcia, Ana Barbara
- Melero, Rebeca
- Tellez-Plaza, Maria
- Sanchez Saez, Francisco|||0000-0002-3011-9884
- Tarazona, Sonia|||0000-0001-5346-1407
[EN] Background: Limited studies have evaluated the joint influence of redox-related metals and genetic variation on metabolic pathways. We analyzed the association of 11 metals with metabolic patterns, and the interacting role of candidate genetic variants, in 1145 participants from the Hortega Study, a population-based sample from Spain. Methods: Urine antimony (Sb), arsenic, barium (Ba), cadmium (Cd), chromium (Cr), cobalt (Co), molybdenum (Mo) and vanadium (V), and plasma copper (Cu), selenium (Se) and zinc (Zn) were measured by ICP-MS and AAS, respectively. We summarized 54 plasma metabolites, measured with targeted NMR, by estimating metabolic principal components (mPC). Redox-related SNPs (N = 291) were measured by oligo-ligation assay. Results: In our study, the association with metabolic principal component (mPC) 1 (reflecting non-essential and essential amino acids, including branched chain, and bacterial co-metabolism versus fatty acids and VLDL subclasses) was positive for Se , Zn, but inverse for Cu, arsenobetaine-corrected arsenic (As) and Sb. The association with mPC2 (reflecting essential amino acids, including aromatic , bacterial co-metabolism) was inverse for Se, Zn and Cd. The association with mPC3 (reflecting LDL subclasses) was positive for Cu, Se and Zn, but inverse for Co. The association for mPC4 (reflecting HDL subclasses) was positive for Sb, but inverse for plasma Zn. These associations were mainly driven by Cu and Sb for mPC1; Se, Zn and Cd for mPC2; Co, Se and Zn for mPC3; and Zn for mPC4. The most SNP-metal interacting genes were NOX1, GSR, GCLC, AGT and REN. Co and Zn showed the highest number of interactions with genetic variants associated to enriched endocrine, car-diovascular and neurological pathways. Conclusions: Exposures to Co, Cu, Se, Zn, As, Cd and Sb were associated with several metabolic patterns involved in chronic disease. Carriers of redox-related variants may have differential susceptibility to metabolic alterations associated to excessive exposure to metals., This work was supported by the Strategic Action for Research in Health sciences [CP12/03080, PI15/00071, PI10/0082, PI13/01848, PI14/00874, PI16/01402, PI21/00506 and PI11/00726] , CIBER Fisio-patologia Obesidad y Nutricion (CIBEROBN) (CIBER-02-08-2009, CB06/03 and CB12/03/30,016) , the State Agency for Research (PID2019-108973RB-C21 and C22) , the Valencia Government (GRU-POS 03/101; PROMETEO/2009/029 and ACOMP/2013/039, IDI-FEDER/2021/072 and GRISOLIAP/2021/119) , the Castilla-Leon Government (GRS/279/A/08) and European Network of Excellence Ingenious Hypercare (EPSS-037093) from the European Commission. The Strategic Action for Research in Health sciences, CIBERDEM and CIBEROBN are initiatives from Carlos III Health Institute Madrid and co-funded with European Funds for Regional Development (FEDER) . The State Agency for Research and Carlos III Health Institute belong to the Spanish Ministry of Science and Innovation. ADR received the support of a fellowship from "la Caixa"Foundation (ID 100010434) (fellowship code "LCF/BQ/DR19/11740016") . MGP received the support of a fellowship from "la Caixa" Foundation (ID 100010434, fellowship code LCFLCF/BQ/DI18/11660001) . The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Project:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 / PID2019-108973RB-C21
,
European Commission / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 / EPSS-037093
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII) / PID2019-108973RB-C22
,
Generalitat Valenciana / GRUPOS 03/101
,
Instituto de Salud Carlos III / PI21/00506
,
Generalitat Valenciana / PROMETEO/2009/029
,
Ministerio de Ciencia e Innovación / PI11/00726
,
Generalitat Valenciana / ACOMP/2013/039
,
Ministerio de Economía y Competitividad / CB12/03/30016
,
Generalitat Valenciana / IDIFEDER/2021/072
,
Ministerio de Economía y Competitividad / CP12/03080
,
Generalitat Valenciana / GRISOLIAP/2021/119
,
Ministerio de Economía y Competitividad / PI13/01848
,
Instituto de Salud Carlos III / PI10/0082
,
Ministerio de Economía y Competitividad / PI14/00874
,
Junta de Castilla y León / GRS/279/A/08
,
Ministerio de Economía y Competitividad / PI15/00071
,
Fundació Bancària Caixa d'Estalvis i Pensions de Barcelona / 100010434
,
Ministerio de Economía y Competitividad / PI16/01402
,
Fundació Bancària Caixa d'Estalvis i Pensions de Barcelona / LCF/BQ/DR19/11740016
,
Ministerio de Sanidad y Consumo / CB06/03/0002
,
Fundació Bancària Caixa d'Estalvis i Pensions de Barcelona / LCFLCF/BQ/DI18/11660001
,
Centro de Investigación Biomédica en Red de Cáncer / CIBER-02-08-2009